Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab Effects on Breast Biomarkers
NCT02613416Phase 2Completed
- Sponsor
- Alison Stopeck
- Start
- Nov 2015
- Primary completion
- Aug 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in breast cancer, sponsored by Alison Stopeck. Started Nov 2015; status: completed.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02613416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613416.